Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trial.
- DOI
- 10.1002/jbmr.4409
- Published
- 2021-08-10
- Container
- J Bone Miner Res
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/jbmr.4409,
title = {Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trial.},
author = {Brown JP and Engelke K and Keaveny TM and Chines A and Chapurlat R and Foldes AJ and Nogues X and Civitelli R and De Villiers T and Massari F and Zerbini CAF and Wang Z and Oates MK and Recknor C and Libanati C.},
year = {2021},
journal = {J Bone Miner Res},
doi = {10.1002/jbmr.4409},
url = {https://doi.org/10.1002/jbmr.4409}
}RIS
TY - JOUR TI - Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trial. AU - Brown JP AU - Engelke K AU - Keaveny TM AU - Chines A AU - Chapurlat R AU - Foldes AJ AU - Nogues X AU - Civitelli R AU - De Villiers T AU - Massari F AU - Zerbini CAF AU - Wang Z AU - Oates MK AU - Recknor C AU - Libanati C. PY - 2021 JO - J Bone Miner Res DO - 10.1002/jbmr.4409 UR - https://doi.org/10.1002/jbmr.4409 ER -
APA
JP, B., K, E., TM, K., A, C., R, C., AJ, F., X, N., R, C., T, D. V., F, M., CAF, Z., Z, W., MK, O., C, R., & C., L. (2021). Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trial.. J Bone Miner Res. https://doi.org/10.1002/jbmr.4409
Source records
- europe-pmc · retrieved 2026-09-26T08:10:35.769Z
- hal · retrieved 2026-09-26T08:10:35.822Z